The effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial

Table 6 Linear mixed model of active vs. placebo at Week 4

	Time point	n	Mean	Std. Deviation	Std. Error Mean	p-value
Diarrhea	Active	147	1.34	2.462	0.203	0.033 *
Diarrhea	Placebo	147	1.69	2.558	0.211	0.033 *
Abdominal cramping	Active	147	1.94	2.341	0.193	0.012 *
Abdominal cramping	Placebo	147	2.39	2.188	0.180	0.012 *
Vomiting	Active	147	.08	.379	0.031	0.0002 **
Vomiting	Placebo	147	.36	.936	0.077	0.0002 **
Audible bowel sounds	Active	147	2.76	2.536	0.209	0.589
Audible bowel sounds	Placebo	147	2.86	2.497	0.206	0.589
Flatulence	Active	148	3.16	2.873	0.236	0.770
Flatulence	Placebo	148	3.21	2.699	0.222	0.770
Overall	Active	147	9.28	9.202	0.759	.037 *
Overall	Placebo	147	10.51	9.327	0.769	.037 *

This table describes all of the time points at week 4, comparing the active versus placebo groups
*statistically significant at p < 0.05; ** statistically significant at p > 0.01

ISSN: 1475-2891